Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

RPG LIFE SCIENCES LTD. - 532983 - Audited Financial Results For The Quarter And Year Ended March 31, 2023

 In terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. April 28, 2023, inter alia, has considered and unanimously: 1. Approved the Audited Financial Results of the Company for the quarter and year ended March 31, 2023. Copy of the same is enclosed along with the Report of the Auditors thereon and a declaration stating that the said report is with unmodified opinion. 2. Recommended equity dividend of Rs. 12 per share of Rs. 8/- each (150%) for the financial year ended March 31, 2023, which will be paid to the shareholders within 30 days of declaration of the same at the ensuing Annual General Meeting. 3. Approved the Audited Financial Statements of the Company, for the year ended March 31, 2023. The Board meeting commenced at 3:00 p.m. and concluded at 6.35 p.m. Kindly take the above on record.
28-04-2023
Bigul

RPG LIFE SCIENCES LTD. - 532983 - Board Meeting Outcome for Outcome Of The Board Meeting Held On April 28, 2023

 In terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. April 28, 2023, inter alia, has considered and unanimously: 1. Approved the Audited Financial Results of the Company for the quarter and year ended March 31, 2023. Copy of the same is enclosed along with the Report of the Auditors thereon and a declaration stating that the said report is with unmodified opinion. 2. Recommended equity dividend of Rs. 12 per share of Rs. 8/- each (150%) for the financial year ended March 31, 2023, which will be paid to the shareholders within 30 days of declaration of the same at the ensuing Annual General Meeting. 3. Approved the Audited Financial Statements of the Company, for the year ended March 31, 2023. The Board meeting commenced at 3:00 p.m. and concluded at 6.35 p.m. Kindly take the above on record.
28-04-2023
Bigul

Annual report for RPG Life Sciences Ltd. for FY-2023
28-04-2023
Bigul

RPG LIFE SCIENCES LTD. - 532983 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Please find enclosed herewith intimation of the loss of share certificate as received by us from Link Intime India Private Limited, our Registrar and Share Transfer Agent, being submitted to you pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Kindly take the same on record.
27-04-2023
Bigul

RPG LIFE SCIENCES LTD. - 532983 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Results Earnings Call for Audited Financial Results of the Company for the quarter and year ended March 31, 2023 will be held on Tuesday, May 2, 2023 at 3.30 p.m. IST. The dial-in details are enclosed herewith. The investor presentation shall be shared with the Exchanges separately. You are requested to kindly take the same on record and disseminate appropriately.
25-04-2023
Bigul

RPG LIFE SCIENCES LTD. - 532983 - Corporate Action-Board to consider Dividend

 Pursuant to the provisions of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that a meeting of the Board of Directors of the Company is scheduled on Friday, April 28, 2023, inter-alia, to: 1. Consider and approve the Audited Financial Results for the quarter and financial year ended March 31, 2023. 2. Recommend dividend, if any, on Equity Shares of the Company for the financial year ended March 31, 2023. Further, pursuant to the 'Code of Fair Disclosure, Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders' of the Company and the SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in Securities of the Company by Designated Persons and their immediate relatives, is closed from April 1, 2023 and will continue to remain closed till 48 hours after declaration of results on April 28, 2023. Kindly take this information on record.
21-04-2023
Bigul

RPG LIFE SCIENCES LTD. - 532983 - Board Meeting Intimation for Intimation Of Board Meeting

 RPG LIFE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/04/2023 ,inter alia, to consider and approve Pursuant to the provisions of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that a meeting of the Board of Directors of the Company is scheduled on Friday, April 28, 2023, inter-alia, to: 1. Consider and approve the Audited Financial Results for the quarter and financial year ended March 31, 2023. 2. Recommend dividend, if any, on Equity Shares of the Company for the financial year ended March 31, 2023. Further, pursuant to the 'Code of Fair Disclosure, Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders' of the Company and the SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in Securities of the Company by Designated Persons and their immediate relatives, is closed from April 1, 2023 and will continue to remain closed till 48 hours after declaration of results on April 28, 2023. Kindly take this information on record.
21-04-2023
Bigul

RPG LIFE SCIENCES LTD. - 532983 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

 Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyRPG LIFE SCIENCES LTD. 2CIN NO.L24232MH2007PLC169354 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Rajesh Shirambekar Designation: Company Secretary and Compliance Officer EmailId: [email protected] Name of the Chief Financial Officer: Vishal Shah Designation: Chief Financial Officer EmailId: [email protected] Date: 19/04/2023 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
19-04-2023
Bigul

RPG LIFE SCIENCES LTD. - 532983 - Compliance Certificate Under Regulation 40(9)

 We enclose herewith certificate issued by Practicing Company Secretary, pursuant to Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the financial year ended March 31, 2023. Kindly take the same on record.
12-04-2023
Bigul

RPG LIFE SCIENCES LTD. - 532983 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 We are enclosing herewith certificate dated April 5, 2023 issued by Link Intime India Private Limited, Registrar and Transfer Agents, confirming compliance under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. Kindly take the same on record.
10-04-2023
Next Page
Close

Let's Open Free Demat Account